Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil · Delayed Price · Currency is BRL 1.180
+0.120 (11.32%)
Jun 17, 2026, 5:05 PM GMT-3
BVMF:ONCO3 Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, BVMF:ONCO3 stock has a consensus rating of "Sell" and an average price target of R$2.48. The average 1-year stock price forecast is 110.17% higher than the current stock price, while the lowest is R$0.70 (-40.68%) and the highest is R$3.50 (+196.61%).
Price Target: R$2.48 (+110.17%)
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for BVMF:ONCO3 stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 2 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Financial Forecast
Revenue This Year
6.24B
from 5.74B
Increased by 8.65%
Revenue Next Year
6.71B
from 6.24B
Increased by 7.60%
EPS This Year
0.14
EPS Next Year
0.14
from 0.14
Decreased by -0.44%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is BRL.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.3B | ||
| Avg | 6.2B | ||
| Low | 6.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.2% | ||
| Avg | 8.6% | ||
| Low | 6.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.14 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -79.4% | ||
| Low | - |